NIGER, MONICA
NIGER, MONICA
Universita' degli Studi di MILANO
BRAF in metastatic colorectal cancer : the future starts now
2015-12-01 A. Orlandi, M.A. Calegari, A. Inno, R. Berenato, M. Caporale, M. Niger, I. Bossi, M.D. Bartolomeo, F. De Braud, F. Pietrantonio
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study
2016-05-01 F. Pietrantonio, R. Berenato, C. Maggi, M. Caporale, M. Milione, F. Perrone, E. Tamborini, D. Baratti, S. Kusamura, L. Mariani, M. Niger, A. Mennitto, A. Gloghini, I. Bossi, G. Settanni, A. Busico, P.F. Bagnoli, M. Di Bartolomeo, M. Deraco, F. de Braud
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study
2018-04-01 M. Di Bartolomeo, M. Niger, G. Tirino, A. Petrillo, R. Berenato, M.M. Laterza, F. Pietrantonio, F. Morano, M. Antista, S. Lonardi, L. Fornaro, S. Tamberi, E. Giommoni, A. Zaniboni, L. Rimassa, G. Tomasello, T. Sava, M. Spada, T. Latiano, A. Bittoni, A. Bertolini, I. Proserpio, K.B. Bencardino, F. Graziano, G. Beretta, S. Galdy, J. Ventriglia, S. Scagnoli, A. Spallanzani, R. Longarini, F. De Vita
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
2019-01-01 F. Corti, F. Nichetti, A. Raimondi, M. Niger, N. Prinzi, M. Torchio, E. Tamborini, F. Perrone, G. Pruneri, M. Di Bartolomeo, F. de Braud, S. Pusceddu
| Titolo | Data di pubblicazione | Autore(i) | Tipo | File | Abstract |
|---|---|---|---|---|---|
| BRAF in metastatic colorectal cancer : the future starts now | 1-dic-2015 | M. NigerI. BossiF. De BraudF. Pietrantonio + | Article (author) | - | |
| GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study | 1-mag-2016 | F. PietrantonioC. MaggiM. NigerA. MennittoF. de Braud + | Article (author) | - | |
| Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study | 1-apr-2018 | M. NigerF. Pietrantonio + | Article (author) | - | |
| Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives | 1-gen-2019 | Corti, FrancescaNichetti, FedericoRaimondi, AlessandraNiger, MonicaPruneri, Giancarlode Braud, FilippoPusceddu, Sara + | Article (author) | - |